Lophora

📍 Herlev, Denmark🗓 Founded 2018👥 8 employees
Biotechnology Research🌐 lophora.com
Website LinkedIn
Lophora is a clinical-stage CNS drug discovery company developing novel, next-generation, neuroactive medicines to treat neurological and psychiatric disorders, such as depressive, anxiety, eating, and mood disorders, PTSD, and substance use disorders. www.lophora.com Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate LPH-5 through funding granted by the BII (Novo Nordisk Foundation), public funds and experienced biotech investors. Lophora will initiate first-in-human trials by 2024. Efficacy of LPH-5 has been extensively characterized in vivo and has successfully completed GLP-Tox with expected CTA submission by Q2 2024.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Lophora founded?
Lophora was founded in 2018.
What industry is Lophora in?
Lophora operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lophora based?
Lophora is headquartered in Herlev, Denmark.